保瑞藥業股份有限公司
保瑞藥業股份有限公司（Bora Pharmaceuticals Co., LTD.）在台灣及國際市場從事藥品委託研製（CDMO）與銷售。製造並銷售學名藥、原廠藥及非處方藥（OTC）。提供中樞神經、抗生素、及腸胃藥物；並為藥廠提供技術服務。通路涵蓋醫療中心、藥局連鎖及診所。公司成立於 2007 年，總部位於台灣台北。
今日上漲 3.23%，股價站回短期均線。該股 RSI(6) 為 71.4，處於偏高區間，短線追高風險提升。股價站上5日、20日、60日、120日均線。短中期均線呈多頭排列，趨勢偏多。KD 指標中性（K=78.3）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | +359 | 0 | +22 | +380 |
| 08-07 | +125 | 0 | +25 | +150 |
| 08-06 | -77 | 0 | -36 | -114 |
| 08-05 | +579 | 0 | +92 | +671 |
| 08-04 | -46 | 0 | -24 | -70 |
| 08-03 | +137 | 0 | +7 | +144 |
| 07-31 | +66 | +1 | -6 | +61 |
| 07-30 | +276 | +1 | +12 | +289 |
| 07-29 | +220 | +1 | -17 | +204 |
| 07-28 | +83 | 0 | -14 | +69 |
| 07-27 | +110 | 0 | -14 | +95 |
| 07-24 | -110 | +1 | -14 | -123 |
| 07-23 | -471 | 0 | -26 | -496 |
| 07-22 | +210 | 0 | +7 | +217 |
| 07-21 | +87 | 0 | -3 | +84 |
| 07-20 | +87 | 0 | -4 | +83 |
| 07-17 | +156 | -2 | -83 | +71 |
| 07-16 | -639 | 0 | +11 | -628 |
| 07-15 | +170 | -2 | +28 | +196 |
| 07-14 | +269 | 0 | -26 | +243 |
| 07-13 | +133 | 0 | -47 | +87 |
| 07-09 | +12 | 0 | -2 | +11 |
| 07-08 | -446 | 0 | +11 | -435 |
| 07-07 | +8 | 0 | -2 | +6 |
| 07-06 | -234 | -1 | -29 | -264 |
| 07-03 | -52 | 0 | +112 | +60 |
| 07-02 | +174 | +1 | +50 | +225 |
| 07-01 | +134 | 0 | -2 | +132 |
| 06-30 | -692 | 0 | -27 | -718 |
| 06-29 | +241 | 0 | +46 | +286 |
| 06-26 | +291 | 0 | -18 | +274 |
| 06-25 | -332 | 0 | -68 | -400 |
| 06-24 | -48 | 0 | +15 | -33 |
| 06-22 | +27 | 0 | +10 | +37 |
| 06-18 | +470 | -18 | +22 | +473 |
| 06-17 | +394 | 0 | +22 | +416 |
| 06-16 | -102 | 0 | +1 | -101 |
| 06-15 | +522 | 0 | +52 | +574 |
| 06-12 | +193 | -1 | +3 | +195 |
| 06-10 | +619 | 0 | -17 | +602 |
| 06-09 | +132 | 0 | -44 | +88 |
| 06-08 | +30 | 0 | +28 | +58 |
| 06-04 | +99 | 0 | +48 | +147 |
| 06-03 | +138 | 0 | 0 | +138 |
| 06-02 | -95 | -3 | -19 | -117 |
| 06-01 | +107 | -14 | +41 | +134 |
| 05-29 | +279 | 0 | +25 | +304 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/06 | 22.98 億 | +8.7% | +39.2% |
| 2026/05 | 21.14 億 | +42.5% | +40.2% |
| 2026/04 | 14.84 億 | -2.9% | -26.4% |
| 2026/03 | 15.28 億 | +15.2% | +4.2% |
| 2026/02 | 13.26 億 | +16.1% | -23.2% |
| 2026/01 | 11.42 億 | -31.1% | -30.2% |
| 2025/12 | 16.57 億 | +10.4% | -16.6% |
| 2025/11 | 15.01 億 | -12.6% | -10.8% |
| 2025/10 | 17.16 億 | -0.2% | -17.9% |
| 2025/09 | 17.21 億 | +25.4% | -15.0% |
| 2025/08 | 13.72 億 | -23.7% | -26.6% |
| 2025/07 | 17.98 億 | - | +4.5% |